Skip to content
Saleshttps://cannpal.com
+61(2)61083622 Ph: +61 (2) 6108 3622
CannPalCannPal Animal Healthinfo@cannpal.com+61(2)6108362249https://cannpal.com
CannPal Logo
Home About Investors Contact Resource Centre

Pet Owners &
Veterinarians

Investors &
Shareholders

A GLOBAL LEADER IN CANNABINOID DERIVED THERAPEUTICS FOR COMPANION ANIMALS


CannPal Animal Therapeutics Limited (ASX: CP1) is a listed animal health company developing innovative and naturally derived plant-based therapeutic products for pets targeting the endocannabinoid system that owners can trust are both safe and scientifically validated.

The company has a research focus on cannabinoids, the active pharmaceutical ingredients extracted from the cannabis plant, to provide veterinarians and pet owners with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

CannPal has identified a significant opportunity to benefit from the rapidly growing medical cannabis and animal health markets by developing innovative therapeutics that can influence the endocannabinoid system with full regulatory approval for veterinary distribution.

 

Learn More

Investors and shareholders

Pet Owners and veterinarians

Innovative and naturally derived therapeutic products


CannPal Animal Therapeutics Limited (ASX: CP1) is a listed animal health company developing innovative and naturally derived plant-based therapeutic products for pets targeting the endocannabinoid system that owners can trust are both safe and scientifically validated.

The company has a research focus on cannabinoids, the active pharmaceutical ingredients extracted from the cannabis plant, to provide veterinarians and pet owners with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

CannPal has identified a significant opportunity to benefit from the rapidly growing medical cannabis and animal health markets by developing innovative therapeutics that can influence the endocannabinoid system with full regulatory approval for veterinary distribution.

A unique investment opportunity in a growing market


CannPal Animal Therapeutics Limited (“CannPal”) is a pharmaceutical-focused animal health company researching the benefits of medical cannabis for companion animals. The company is listed on the Australian Stock Exchange (ASX) in 2017, trading under the ASX ticker “CP1”. CannPal was founded to research, develop and commercialise, regulatory approved medicines derived from the medical cannabis plant to provide veterinarians with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

  • About
    Read More
  • Cannabis safety & FAQs
    Read More
  • The EndoCannabinoid System
    Read More
  • Products
    Read More
  • Plant Nutrition
    Read More
  • Resource Centre
    Read More
  • Corporate Governance
    Read More
  • Corporate Directory
    Read More
  • Stock & Financial Information
    Read More
  • ASX Announcements
    Read More
  • Information Request
    Read More
  • Media Centre
    Read More

  • SUBSCRIBE

Invest in CannPal

CannPal Animal Therapeutics Limited (“CannPal”) is a pharmaceutical-focused animal health company researching the benefits of medical cannabis for companion animals. The company is listed on the Australian Stock Exchange (ASX) in 2017, trading under the ASX ticker “CP1”. CannPal was founded to research, develop and commercialise, regulatory approved medicines derived from the medical cannabis plant to provide veterinarians with clinically validated and standardised therapeutics to treat animals in a safe and ethical way.

Learn More

CannPal Logo
info@cannpal.com +61 (2) 6108 3622 Privacy Policy
Copyright © CannPal 2021. All rights reserved. Designed and Developed by Web Bird Digital

Sorry to interrupt

Want to be the first to know about the latest developments in the animal cannabinoid therapeutics industry?

Sign up to our monthly newsletter to keep up-to-date!

  • SUBSCRIBE

View our Privacy Policy